Paul Jeng
Stock Analyst at Guggenheim
(2.23)
# 2,790
Out of 4,996 analysts
4
Total ratings
100%
Success rate
4.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Paul Jeng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Assumes: Neutral | n/a | $34.02 | - | 1 | Sep 18, 2025 | |
| IMTX Immatics | Initiates: Buy | $16 | $7.70 | +107.79% | 1 | Sep 18, 2025 | |
| CNTX Context Therapeutics | Initiates: Buy | $5 | $0.91 | +449.45% | 1 | Sep 18, 2025 | |
| IDYA IDEAYA Biosciences | Initiates: Buy | $50 | $26.83 | +86.36% | 1 | Sep 18, 2025 |
Immunocore Holdings
Sep 18, 2025
Assumes: Neutral
Price Target: n/a
Current: $34.02
Upside: -
Immatics
Sep 18, 2025
Initiates: Buy
Price Target: $16
Current: $7.70
Upside: +107.79%
Context Therapeutics
Sep 18, 2025
Initiates: Buy
Price Target: $5
Current: $0.91
Upside: +449.45%
IDEAYA Biosciences
Sep 18, 2025
Initiates: Buy
Price Target: $50
Current: $26.83
Upside: +86.36%